Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination-Reference-Cited by-同舟云学术

Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination

Published:2018-06 Issue: Volume:50 Page:72-79
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

McShane Pamela J.,Weers Jeffry G.^ORCID,Tarara Thomas E.,Haynes Alfred,Durbha Preeti,Miller Danforth P.,Mundry Tobias,Operschall Elisabeth,Elborn J. Stuart^ORCID

Funder

highfield:communication, Oxford, UK

Fusion MD, Montreal, Canada

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference55 articles.

1. Prevalence and economic burden of bronchiectasis;Weycker;Clin. Pulm. Med.,2005

2. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis;Chalmers;Am. J. Respir. Crit. Care Med.,2012

3. Clinical applications of pulmonary delivery of antibiotics;Flume;Adv. Drug Deliv. Rev.,2015

4. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation;Tunney;Am. J. Respir. Crit. Care Med.,2013

5. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis;Barker;Am. J. Respir. Crit. Care Med.,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication;International Journal of Pharmaceutics;2024-06

2. Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives;Pharmaceutics;2024-05-11

3. Co-spray dried inhalable composite powders of ciprofloxacin and alginate oligosaccharide as anti-biofilm therapy;International Journal of Pharmaceutics;2024-04

4. Pulmonary inhalation for disease treatment: Basic research and clinical translations;Materials Today Bio;2024-04

5. Design of dry powder inhalers to improve patient outcomes: it’s not just about the device;Expert Opinion on Drug Delivery;2024-03-03